Amiodarone-induced pulmonary toxicity-A fatal case report and literature review

Cardiovascular Drugs and Therapy

Volumn 27, Issue 3, 2013, Pages 247-254

  Range, Felix T ^a,b   Hilker, Ekkehard ^a   Breithardt, Günter ^a   Buerke, Boris ^a   Lebiedz, Pia ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Amiodarone pulmonary toxicity; Atrial fibrillation; Dosage patterns; Heart failure; Overdosage

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PREDNISOLONE; SOTALOL; ANTIARRHYTHMIC AGENT;

ABNORMAL LABORATORY RESULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBIOTIC THERAPY; BRONCHOSCOPY; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG INTOXICATION; DRUG OVERDOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ECTOPIC ATRIAL TACHYCARDIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HEPATITIS; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYPERTHYROIDISM; HYPERTRANSAMINASEMIA; HYPOTHYROIDISM; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; INTERSTITIAL PNEUMONIA; INTUBATION; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOCYTOSIS; LIVER FUNCTION; LUNG ASSIST DEVICE; LUNG TOXICITY; MALE; MEDICAL HISTORY; NEUROLOGIC DISEASE; NONINVASIVE VENTILATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUDDEN CARDIAC DEATH; THORAX RADIOGRAPHY; ARTICLE; CHEMICALLY INDUCED DISORDER; FATALITY; HALF LIFE TIME; INTERSTITIAL LUNG DISEASE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CORONARY ARTERY DISEASE; DRUG OVERDOSE; FATAL OUTCOME; HALF-LIFE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84886394179     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-013-6446-0     Document Type: Review

References (35)

1. Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest. 1988;93:1242-8.
2. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol. 1990;16:1711-8.
3. Navarro-López F, Cosin J, Marrugat J, Guindo J, Bayes de Luna A. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. Am J Cardiol. 1993;72:1243-8.
4. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 1994;344:493-8.
5. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997;349:675-82.
6. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667-74.
7. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol. 2003;41:1707-12.
8. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-302.
9. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-33.
10. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356:1789-94.
11. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834-40.
12. Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within 2 weeks of initiation of amiodarone. Am J Cardiol. 2002;89:896-8.
13. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the ACC/AHA Task Force on Practice Guidelines and the ESC Committee for Practice Guidelines. Circulation. 2006;114:e257-354.
14. Goldschlager N, Epstein AE, Naccarelli GV, et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Hear Rhythm. 2007;4:1250-9.
15. Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J. 1991;121:158-71.
16. Piccini JP, Berger JS, O'Connor CM. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:1245-53.
17. Tuseth V, Jaatun HJ, Dickstein K. Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment. Heart. 2005;91:964-5.
18. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379: 648-61.
19. Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest. 2001;120:275-82.
20. Camus P, Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Clin Chest Med. 2004;25:65-75.
21. RotmenschHH, LironM, Tupilski M, Laniado S. Possible association of pneumonitis with amiodarone therapy. Am Heart J. 1980;100:412-3.
22. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet. 1997; 350:1417-24.
23. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation. 1990;82:51-9.
24. Heger JJ, Prystowsky EN, Zipes DP. Relationships between amiodarone dosage, drug concentrations, and adverse side effects. Am Heart J. 1983;106:931-5.
25. Rotmensch HH, Belhassen B, Swanson BN, et al. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med. 1984;101:462-9.
26. Polkey MI,Wilson PO, Rees PJ. Amiodarone pneumonitis: no safe dose. Respir Med. 1995;89:233-5.
27. Kuhlman JE, Teigen C, Ren H, et al. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology. 1990;177:121-5.
28. Rakita L, Sobol SM, Mostow N, Vrobel T. Amiodarone pulmonary toxicity. Am Heart J. 1983;106:906-16.
29. Rote Liste 2011. Arzneimittelinformation für Deutschland. Frankfurt/Main: Rote Liste Service GmbH; 2011.
30. Libby P, Bonow RO, Zipes DP, Mann DL, eds. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelhia: Saunders; 2008.
31. Camm J, Lüscher TF, Serruys PW. The ESC textbook of cardiovascular medicine. 2nd ed. New York: Oxford University Press; 2009.
32. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation. 1995;92:3264-72.
33. Kalbfleisch SJ, Williamson B, Man KC, et al. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia. JACC. 1993;22:1723-9.
34. Collaborative Group for Amiodarone Evaluation. Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Am J Cardiol. 1984;53:1564-9.
35. Ahmed S, Ranchor AV, Crijns HJGM, Van Veldhuisen DJ, Van Gelder IC, investigators ftC. Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation. Europace. 2010;12:785-91.